phrykt

Firefly Neuroscience, Inc. (AIFF): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of AIFF were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No AIFF insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

AIFF short interest

Low short interest. 3.5% of AIFF shares are sold short: about 1 share in 28. Over the last 12 reports the number of shares short went down 39%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 553,621 AIFF shares were sold short, 3.5% of the shares outstanding, down 26.3% from the report before. At the average daily volume of 103,426 shares, buying them all back would take about 5.3 trading days (days to cover).

Shares short, % of all shares

3.53%May 15Oct 307.76%

Days to cover

5.3May 15Oct 308.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026553,6213.53%-26%103,4265.3
Oct 15, 2026751,1944.79%-32%260,1812.9
Sep 30, 20261.10M7.00%+265%14.58M1.0
Sep 15, 2026300,8631.92%-29%60,6065.0
Aug 31, 2026422,2202.69%-12%75,6945.6
Aug 14, 2026477,2023.04%-20%167,2922.9
Jul 31, 2026598,4584.05%-9%106,3955.6
Jul 15, 2026655,6904.43%-7%83,2347.9
Jun 30, 2026702,4894.75%-6%206,5153.4
Jun 15, 2026747,6505.05%+1%458,4361.6
May 29, 2026738,8544.99%-19%194,5003.8
May 15, 2026913,0666.17%-11%304,0823.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Firefly Neuroscience company events

Firefly Neuroscience filed 9 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Sep 14, 2026.

  1. Sep 14, 2026LeadershipThe board of directors of Firefly Neuroscience, Inc., a Delaware corporation, terminated Paul Krzywicki as Chief Financial Officer of the Company, effective September 24, 2026. Filing
  2. Aug 7, 2026LeadershipAt the 2026 annual meeting of stockholders of Firefly Neuroscience, Inc., a Delaware corporation, the Company’s stockholders approved Amendment No. 2 to the Firefly Neuroscience, Inc. 2024 Long-Term Incentive Plan, which amended the Firefly Neuroscience, Inc. 2024 Long-Term Incentive Plan (as… Filing
  3. Jun 26, 2026AgreementEnded an important agreement. Filing
  4. Jun 22, 2026LeadershipDeel Innovation Ltd., which provides consulting services to Firefly Neuroscience, Inc., a Delaware corporation, entered into an employment agreement with Gil Issachar, formerly the Chief Technology Officer of the Company, pursuant to which Issachar now serves as the Head of AI and Neuroscience of… Filing
  5. May 12, 2026AgreementFirefly Neuroscience, Inc., a Delaware corporation, entered into a securities purchase agreement with an accredited investor, pursuant to which the Company agreed to issue and sell to the Investor up to 666,667 units, at a purchase price of $1.50 per Unit, for aggregate gross proceeds of up to $1… Filing
  6. Apr 22, 2026AgreementAs previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 12, 2026, Firefly Neuroscience, Inc., a Delaware corporation, entered into a Securities Purchase Agreement, dated as of March 8, 2026, with certain accredited investors… Filing
  7. Mar 12, 2026AgreementFirefly Neuroscience, Inc., a Delaware corporation entered into a securities purchase agreement with certain accredited investors (each an “Investor” and, collectively the “Investors”), pursuant to which the Company agreed to issue and sell up to 13,500,000 of units, at a purchase price of $1.50… Filing
  8. Feb 4, 2026LeadershipFirefly Neuroscience Ltd., a wholly-owned subsidiary of the Company, entered into an addendum to the Personal Employment Agreement dated February 2, 2017, and a Contract Addendum dated June 21, 2021, with Gil Issachar, the Company's Chief Technology Officer. Filing
  9. Dec 19, 2025AgreementFirefly Neuroscience, Inc., a Delaware corporation, entered into a Warrants Cancellation and Exchange Agreement, dated as of December 16, 2025 between the Company and each of certain investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Firefly Neuroscience financials

Famous investors that hold AIFF

1 of the 50 well-known investors we track reported holding AIFF in their latest 13F filing. The largest position is Ken Griffin's, worth $59.5K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202638,910$59.5K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Firefly Neuroscience, Inc. (AIFF) stock

Are AIFF insiders buying or selling?

No AIFF insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in AIFF?

As of Oct 30, 2026, 553,621 AIFF shares were sold short, 3.5% of the shares outstanding, down 26.3% from the report before. At the average daily volume of 103,426 shares, buying them all back would take about 5.3 trading days (days to cover). See the history.

Which famous investors hold AIFF?

1 of the 50 well-known investors we track reported AIFF in their latest 13F filing, including Ken Griffin. The largest position is worth $59.5K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.